| P2093 | author name string | Tadashi Toyama | |
| | Takashi Yasuda | |
| | Takashi Wada | |
| | Katsuomi Matsui | |
| | Kenjiro Kimura | |
| | Takeshi Sugaya | |
| | Kengo Furuichi | |
| | Shinobu Tatsunami | |
| | Atsuko Kamijo-Ikemori | |
| | Naohiko Imai | |
| | Yugo Shibagaki | |
| | Miho Shimizu | |
| P2860 | cites work | Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery | Q24651494 |
| | Metabolic syndrome and kidney disease: a systematic review and meta-analysis | Q26863240 |
| | Urinary fatty acid–binding protein as a new clinical marker of the progression of chronic renal disease | Q29040146 |
| | End-stage renal disease in African-American and white men. 16-year MRFIT findings | Q34422194 |
| | Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients | Q34583376 |
| | Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors | Q34658067 |
| | Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis | Q34660044 |
| | Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity | Q34760887 |
| | Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules | Q35103241 |
| | Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature | Q35442203 |
| | Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathy | Q36782780 |
| | Insulin and its role in chronic kidney disease | Q36967815 |
| | Urinary biomarkers in the early diagnosis of acute kidney injury | Q36982595 |
| | Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage | Q37197335 |
| | Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. | Q37406875 |
| | Novel urinary biomarkers in early diabetic kidney disease | Q38219572 |
| | Revised equations for estimated GFR from serum creatinine in Japan | Q39513402 |
| | Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study | Q39599282 |
| | Renal L-type fatty acid--binding protein in acute ischemic injury. | Q40066301 |
| | Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction | Q42796390 |
| | Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes | Q43242660 |
| | Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial | Q46472181 |
| | Experimental chronic renal ischemia: morphologic and immunologic studies | Q46602371 |
| | Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease | Q46987400 |
| | Blood Pressure Predicts Risk of Developing End-Stage Renal Disease in Men and Women | Q47960312 |
| | Performance of GFR equations in Japanese subjects. | Q51308712 |
| | Blood pressure and end-stage renal disease in men | Q71574790 |
| | Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization | Q79811373 |
| | Usefulness of urinary biomarkers in early detection of acute kidney injury after cardiac surgery in adults | Q82560691 |
| | Clinical significance of tubular and podocyte biomarkers in acute kidney injury | Q82866165 |
| | Evidence-based practice guideline for the treatment of CKD | Q84978295 |
| | Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2 | Q87437487 |
| P433 | issue | 2 | |
| P304 | page(s) | 195-203 | |
| P577 | publication date | 2015-07-19 | |
| P1433 | published in | Clinical and experimental nephrology | Q26842022 |
| P1476 | title | Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD | |
| P478 | volume | 20 | |